- Progeroid syndromes are a group of rare genetic disorders characterised by the accelerated appearance of ageing features early in life. Although they mimic many aspects of natural ageing, they arise from specific mutations that disrupt fundamental cellular processes such as DNA repair, nuclear‑lamina stability, telomere maintenance and mitochondrial function. Individuals with progeroid syndromes exhibit symptoms typically associated with advanced age, including growth retardation, hair loss, skin thinning, bone abnormalities and early onset of cardiovascular or metabolic disease. These conditions provide powerful insight into the molecular mechanisms that drive human ageing and highlight how defects in genome maintenance and cellular architecture can dramatically shorten healthspan.
- One of the best‑known progeroid disorders is Hutchinson–Gilford progeria syndrome (HGPS), caused by mutations in the LMNA gene. This mutation leads to the production of progerin, an abnormal form of lamin A that disrupts nuclear structure and impairs chromatin organisation. Cells expressing progerin accumulate DNA damage, exhibit altered gene expression and undergo premature senescence. Clinically, children with HGPS develop growth failure, loss of subcutaneous fat, joint stiffness and severe cardiovascular disease, often leading to early mortality. The study of HGPS has revealed how nuclear‑lamina integrity is essential for maintaining genomic stability and regulating the pace of ageing.
- Werner syndrome represents another major progeroid condition, caused by mutations in the WRN gene, which encodes a RecQ helicase involved in DNA repair, replication and telomere maintenance. Individuals with Werner syndrome typically appear normal during childhood but begin to show signs of premature ageing in early adulthood, including early greying of hair, cataracts, skin atrophy, diabetes and increased cancer risk. WRN deficiency leads to genomic instability, accelerated telomere shortening and impaired cellular proliferation, demonstrating how DNA‑repair pathways are central to preventing early onset of ageing phenotypes.
- Other progeroid syndromes arise from defects in nucleotide‑excision repair, as seen in disorders involving ERCC1 or XPA. These conditions result in extreme sensitivity to DNA damage, neurological decline and systemic premature ageing. Dyskeratosis congenita, caused by mutations in telomerase components such as TERT or TERC, leads to critically short telomeres, bone‑marrow failure, skin abnormalities and early organ dysfunction. These telomere‑related progeroid syndromes highlight how telomere attrition accelerates cellular senescence and limits tissue regeneration.
- Mitochondrial dysfunction also contributes to progeroid phenotypes. Mutations in genes such as POLG impair mitochondrial DNA replication, leading to reduced energy production, increased oxidative stress and early onset of neuromuscular and systemic ageing features. Chronic inflammation further accelerates progeroid pathology, with elevated levels of SASP cytokines such as IL‑6 and TNF‑α creating a pro‑ageing environment that disrupts tissue homeostasis.
- Clinically, progeroid syndromes vary in severity, onset and organ involvement, but they share a common theme: the premature activation of biological ageing pathways due to defects in genome maintenance, nuclear structure or telomere biology. These disorders have become essential models for understanding human ageing, revealing how specific molecular failures can dramatically accelerate the decline of cellular function. Research into progeroid syndromes continues to inform therapeutic strategies aimed at improving DNA repair, stabilising nuclear architecture, enhancing mitochondrial function and reducing chronic inflammation.
